Intel Sold $23 Billion of Stock at $95 in August. It Reports Oct. 29 at $87, 38% Below Its June High.

Intel Sold 23 Billion of Stock at 95 in August. It Reports Oct. 29 at $87, 38% Below Its June High.

Key Takeaways

Intel Corporation’s $23 billion equity sale priced at $95 in August now sits 8.5% above the October 23 close of $86.96, turning a financing meant to fund expansion into a visible test of investor confidence.
The operating evidence is materially better than the chart: second-quarter revenue grew 25%, data-center and artificial-intelligence revenue rose 59%, and non-GAAP gross margin reached 41.8%, but cash consumption and rising capital spending make the quality of that growth the central question.
The October 29 report is a confirmation test, not a routine earnings event: revenue against the $16.50 billion consensus, gross margin against the 42% guide, and the fourth-quarter supply outlook will show whether the back-loaded supply growth management described has arrived.

INTC priced its August offering at $95, initially targeting $15 billion before increasing it to $20 billion and selling the underwriters’ full additional allotment. In total, roughly 242.1 million new shares were issued for approximately $23 billion in gross proceeds. The stated purpose was to fund capital spending and working capital while preserving an investment-grade balance sheet.

That financing decision made sense against the company’s own operating message. Customers were signaling strong demand, server supply was described as tighter than available production, and management was increasing investment in equipment, clean-room capacity, and substrates. The offering gave Intel cash to pursue that opportunity while its stock was still trading well above the current level.

The market has since delivered a harsher interpretation. At $86.96, Intel is 8.5% below the offering price, so the equity raise did not establish a durable valuation floor. Instead, it created a reference point: investors are now paying less for the company than the new capital was willing to pay in August, even though the proceeds are intended to expand the very capacity that management says customers need.

That gap matters because the offering also diluted existing owners. The new shares increased the resources available for the build-out, but they also increased the future earnings burden. Intel must now generate enough incremental revenue, margin, and cash flow to justify both the larger investment base and the larger share count. The October report is the first major opportunity to show that the financing was acceleration rather than financial defense.

The Operating Story Improved Faster Than the Stock’s Confidence

Intel’s second-quarter results provide a strong fundamental starting point. Revenue reached $16.1 billion, up 25% year over year, which management described as its strongest growth in more than fifteen years. Data Center and AI revenue grew 59% to $6.3 billion, substantially outpacing the 13% increase in Client Computing and Physical AI revenue.

The mix is important. A recovery led only by PCs would be vulnerable to the expected low-double-digit decline in PC consumption during 2026. The faster-growing data-center business offers a more valuable source of demand, and management said server demand continued to run ahead of supply. That combination suggests Intel is not trying to fund capacity into an empty market; the immediate problem is converting demand into deliverable units.

Margins also improved sharply. Non-GAAP gross margin was 41.8%, about 12 percentage points above the prior-year level and roughly 280 basis points ahead of the company’s guidance. Non-GAAP operating margin reached 17.2%, compared with a negative 3.9% a year earlier. Those figures support the view that operating leverage is returning as utilization and product mix improve.

Yet the earnings quality is not simple. Intel reported a GAAP loss of $11.0 billion, while non-GAAP earnings were $0.42 per share. The main GAAP distortion was a non-cash mark-to-market loss on shares held in escrow for the U.S. Department of Commerce under Intel’s CHIPS Act Secure Enclave agreement. That accounting item can swing with Intel’s stock price and does not represent the same economic event as an operating cash loss.

The more relevant concern is cash. Adjusted free cash flow was negative $8.4 billion in the second quarter, even as operating cash flow was $7.0 billion. Intel’s capital spending plan now calls for more than $20 billion in 2026 and significantly more in 2027. The business is growing, but the expansion is consuming capital before the returns are visible.

October 29 Must Prove That Supply, Not Demand, Is the Constraint

The company’s own guidance sets a narrow test. Third-quarter revenue was guided to a range of $15.8 billion to $16.8 billion, with a midpoint of $16.3 billion, while the consensus sits at $16.50 billion. Non-GAAP gross margin was guided to 42%, and consensus earnings were approximately $0.40 per share against company guidance of $0.38.

The arithmetic reveals the market’s hurdle: consensus is about $200 million above the revenue midpoint and slightly above the earnings guide. A result merely inside management’s range may therefore be operationally acceptable but commercially disappointing if the report does not also improve the fourth-quarter outlook.

Management previously warned that supply growth would be skewed toward the end of the third quarter and into the fourth quarter, especially for servers. That wording makes the forward guide more important than the quarter just completed. If supply expanded as promised, investors should see evidence in revenue acceleration, data-center growth, or a stronger fourth-quarter outlook. If those items remain deferred, the market will have more reason to question whether Intel can monetize the demand it describes.

The report also needs to distinguish demand from execution. Intel said the server industry could experience strong double-digit unit growth this year and next, but demand alone does not pay for new factories. The key question is whether additional units can be produced at margins high enough to support the capital budget.

A useful result would therefore have three parts: revenue at or above the $16.50 billion consensus, gross margin at least meeting the 42% guide, and a fourth-quarter outlook that shows supply becoming more available rather than simply promising improvement later. Data Center and AI growth and any update on next-generation manufacturing customer engagement will help investors judge whether the expansion has commercial traction.

The Chart Says the Market Is Pricing Execution Risk

Intel closed October 23 at $86.96 after falling 8.0% on October 22 and recovering 1.7% the next session. Since the October 12 close of $101.35, the stock has fallen about 14.2%. That is not a gradual repricing of a single quarterly estimate; it is a concentrated reduction in the premium investors were willing to pay for the capacity story.

The larger drawdown is more severe. The stock is 38.3% below its June 22 record close of $140.94 and 27.7% below the September 30 close of $120.23. It remains about 1% above its 200-day average of $85.81, while sitting well below its 50-day average of $102.11. The resulting pattern is clear: short-term momentum has broken, but the longer-term uptrend has not yet decisively failed.

That distinction gives the October report unusual technical importance. A strong report could reclaim the offering price and begin repairing the distance from the 50-day average. A weak report could push the stock below the 200-day average, converting a sharp correction into a more consequential trend break.

The selloff also occurred in a weak semiconductor tape. The sector index recorded eight consecutive down sessions through October 16, and Intel’s 8.0% October 22 decline was larger than the 6.8% fall in the iShares Semiconductor ETF that day. There was no Intel-specific explanation identified for that session, so the move should not be treated as a clean verdict on the company. Still, Intel has additional exposure to execution questions, including competition for advanced packaging capacity, that make it more vulnerable when investors reduce risk across the group.

Intel daily chart with technical signals, through the Oct 23 close Intel daily chart with technical signals, through the Oct 23 close

Funding Strength and Financial Strain Are the Same Story

The $23 billion raise materially improves Intel’s ability to fund the build-out. Debt was approximately $50.5 billion against cash and short-term investments of about $29.7 billion, so new equity avoids forcing all incremental investment onto the balance sheet. That is a genuine strategic advantage in a capital-intensive manufacturing race.

But the financing does not eliminate the economic burden. It transfers part of the risk from lenders to shareholders while increasing the number of shares over which future earnings must be distributed. The company must therefore demonstrate returns, not merely access to capital.

The contrast between growth and free cash flow captures the issue. Second-quarter revenue rose 25%, but adjusted free cash flow was negative $8.4 billion. Capital spending is expected to exceed $20 billion this year and rise significantly above that level next year. If revenue growth and gross margin improve alongside that spending, the negative cash flow can be interpreted as investment ahead of demand. If margins stagnate, the same figures become evidence of an expensive capacity build with uncertain returns.

The discount below $95 can be read as a question of timing. Investors are not necessarily rejecting the demand thesis. They are demanding proof that Intel can produce enough to meet that demand, that incremental capacity will earn an acceptable return, and that dilution will be offset by earnings growth. October 29 cannot answer the full return-on-investment question, but it can show whether the first step is working.

The Consensus Is Positive on Value but Not on Near-Term Momentum

Conventional analyst positioning is supportive but far from unanimous. The consensus twelve-month target is $118.56, with a median of $114 and a broad range from $80 to $200. There are 32 buy ratings, 47 holds, and 6 sells. Holds outnumber buys, which fits a stock where the long-term opportunity is visible but the near-term execution path remains disputed.

The target implies roughly 36% upside from the October 23 close. That is a meaningful spread, but the range is wide enough that the consensus target should be treated as a low-confidence reference rather than a precise valuation signal. The distance between the $80 low target and the $200 high target reflects disagreement over how much of Intel’s manufacturing and artificial-intelligence opportunity becomes profitable.

The quantitative read is more cautious than the operating growth figures. Intel’s composite score is 23, its technical rating is 35, and its moving-average score is 16. Those readings all point to weak current positioning rather than a stock being broadly recognized as healthy after its correction.

That split is the central signal combination. Fundamental progress and strategic funding support a recovery case, while price trend and quantitative positioning say the market is not yet ready to pay for that recovery. The scores do not forecast the report, but they show the market has not yet priced in the next leg of supply growth.

What Comes Next

The October 29 report is the first chance to check the August thesis against numbers. The clearest tests are revenue against the $16.50 billion consensus and the $15.8 billion to $16.8 billion guide, non-GAAP gross margin against 42%, earnings against roughly $0.40 a share, Data Center and AI growth after a 59% second quarter, and a fourth-quarter outlook that either shows server supply arriving or pushes it out again. Any update to the more-than-$20 billion 2026 capital budget, the 2027 plan, or 14A customer engagement will shape how investors judge the return on the new capital.

History says the reaction can be large in either direction. The shares fell 7.9% after the July report despite a revenue and profit beat, rose 23.6% after the April report, and fell 17.0% after the January report.

Price levels frame that reaction. Friday’s $86.96 close sits about 1% above the $85.81 200-day average, 8.5% below the $95 offering price, and well below the $102.11 50-day average. Where the stock trades relative to those three levels after the report will show whether investors see the raise as funding growth or as covering for it.

Intel does not need another promise of demand; it needs evidence that funded capacity is becoming profitable supply.

Want deeper research on any stock? Try Kavout Pro for AI-powered analysis, smart signals, and more. Already a member? Add credits to run more research.